are all expressed by subpopulations of nociceptive primary sensory neurons. Thus, NAPE-PLD, TRPV1, the CB1 receptor, and FAAH could form an autocrine signaling system that could shape the activity of a major subpopulation of nociceptive primary sensory neurons, contributing to the development of pain. Although the expression patterns of TRPV1, the CB1 receptor, and FAAH have been comprehensively elucidated, little is known about NAPE-PLD expression in primary sensory neurons under physiological and pathological conditions. This study shows that NAPE-PLD is expressed by about one-third of primary sensory neurons, the overwhelming majority of which also express nociceptive markers as well as the CB1 receptor, TRPV1, and FAAH. Inflammation of peripheral tissues and injury to peripheral nerves induce differing but concerted changes in the expression pattern of NAPE-PLD, the CB1 receptor, TRPV1, and FAAH. Together these data indicate the existence of the anatomical basis for an autocrine signaling system in a major proportion of nociceptive primary sensory neurons and that alterations in that autocrine signaling by peripheral pathologies could contribute to the development of both inflammatory and neuropathic pain.
| I N T R O D U C T I O N
N-arachidonoylethanolamine (anandamide) is a lipid signaling molecule (Devane et al., 1992) that is synthesized both in a Ca 21 -insensitive and in a Ca
21
-sensitive manner through multiple enzymatic pathways and a single pathway that involves the activity of N-acylphosphatidylethanolamine phospholipase D (NAPE-PLD; Okamoto, Morishita, Tsuboi, Tonai, & Ueda, 2004; Ueda, Liu, & Yamanaka, 2001; Wang et al., 2006; Wang, Okamoto, Tsuboi, & Ueda, 2008) . Although anandamide acts on a series of molecules, the transient receptor potential vanilloid type 1 ion channel (TRPV1; Caterina et al., 1997) and the cannabinoid 1 (CB1) receptor (Matsuda, Lolait, Brownstein, Young, & Bonner, 1990 ) are believed to be anandamide's main targets (Devane et al., 1992; Zygmunt et al., 1999) .
Activation of TRPV1 results in the opening of this nonselective cationic channel and subsequent excitation of nociceptive primary sensory neurons, whereas activation of the CB1 receptor is believed to produce an inhibitory effect that includes the inhibition of L-, P/Q-, and N-type voltage-gated Ca 21 channels in neurons, including primary sensory neurons (Caterina et al., 1997; Mackie & Hille, 1992; Mackie, Lai, Westenbroek, & Mitchell, 1995; Tominaga et al., 1998; Twitchell, Brown, & Mackie, 1997) .
The CB1 receptor and TRPV1 are coexpressed by various neurons, including a great proportion of nociceptive primary sensory neurons (Agarwal et al., 2007; Ahluwalia, Urban, Capogna, Bevan, & Nagy, 2000; Binzen et al., 2006; Mitrirattanakul et al., 2006) . This anatomical arrangement allows exogenous anandamide to control the activity of neurons, including a major group of nociceptive primary sensory neurons (Ahluwalia, Urban, Bevan, & Nagy, 2003) .
Anandamide is synthesized in subpopulations of primary sensory neurons in both Ca
-sensitive and Ca
-insensitive manners Varga et al., 2014; Vellani et al., 2008) . Consistent with the ability of a group of primary sensory neurons to synthesize anandamide in a Ca
-sensitive manner and the role of NAPE-PLD in such anandamide synthesis (Okamoto et al., 2004; Ueda et al., 2001; Wang et al., 2006 Wang et al., , 2008 , NAPE-PLD mRNA is expressed by primary sensory neurons . Most of the NAPE-PLD mRNA-expressing cells are capsaicin sensitive ), so they should also express TRPV1 and the CB1 receptor (Agarwal et al., 2007; Ahluwalia et al., 2000; Binzen et al., 2006; Mitrirattanakul et al., 2006) . Therefore, in addition to exogenous anandamide, anandamide of primary sensory neuron origin could also be able to control TRPV1 and CB1 receptor activity in a major subpopulation of nociceptive primary sensory neurons in an autocrine manner .
In addition to NAPE-PLD and the CB1 receptor, the great majority of TRPV1-expressing primary sensory neurons also express the main anandamide-hydrolyzing enzyme fatty acid amide hydrolase (FAAH; Cravatt et al., 1996; Lever et al., 2009 ). Blocking FAAH activity through increasing the level of anandamide also results in regulating the activity of a proportion of nociceptive primary sensory neurons through the CB1 receptor and TRPV1 (Lever et al., 2009) . Based on the coexpression pattern of TRPV1, the CB1 receptor, NAPE-PLD, FAAH, and the effects of those molecules, the presence of an endocannabinoid/endovanilloid autocrine signaling system built by those molecules has been proposed in a major subpopulation of nociceptive primary sensory neurons (Sousa- Valente, Varga, Ananthan, Khajuria, & Nagy, 2014; . That autocrine signaling system, through TRPV1-and CB1 receptor-mediated changes in the intracellular Ca 21 concentration and subsequent NAPE-PLDmediated anandamide synthesis as well as FAAH-mediated anandamide hydrolysis, is considered to be prominently suitable to provide a significant control over TRPV1 and CB1 receptor activity in and, hence, over the excitation of a major group of nociceptive primary sensory neurons (Sousa-Valente, Varga, Ananthan, K., Khajuria, A., & Nagy, I. 2014; Varga et al., 2014) .
The excitation level of nociceptive primary sensory neurons is pivotal for the initiation and maintenance of pain experiences, including those that are associated with peripheral pathologies, such as inflammation of peripheral tissues and injury to peripheral nerves (Nagy, Santha, Jancso, & Urban, 2004; Sousa-Valente, Andreou, Urban, & Nagy, 2014) . Therefore, the control provided by the endocannabinoid/endovanilloid autocrine signaling system built by the CB1 receptor, TRPV1, NAPE-PLD, and FAAH in a major group of nociceptive primary sensory neurons might play an important role in the development and maintenance of pain. Although the expression patterns and the changes in those expression patterns by pathological conditions of the CB1 receptor, TRPV1, and FAAH have been comprehensively elucidated (Amaya et al., 2004 (Amaya et al., , 2006 Bar, Schaible, Brauer, Halbhuber, & von Banchet, 2004; Hudson et al., 2001; Ji, Samad, Jin, Schmoll, & Woolf, 2002; Lever et al., 2009; Luo, Cheng, Han, & Wan, 2004; Malek et al., 2015; Mitrirattanakul et al., 2006; Yu et al., 2008; Zhou, Li, & Zhao, 2003) , little is known about those properties and changes of NAPE-PLD. Therefore, to improve our understanding of the putative autocrine cannabinoid/endovanilloid signaling in primary sensory neurons, this article describes the coexpression patterns of NAPE-PLD with TRPV1, the CB1 receptor, and FAAH under naive conditions and changes in those expression patters under pathological conditions. Preliminary findings were reported earlier by Valente et al. (2011) .
| M E T H O D S AN D M A T E R I A L S
Forty-two male Wistar rats (250-300 g) and 10 C57BL/6 wild-type (WT) and 10 NAPE-PLD -/- (Leung, Saghatelian, Simon, & Cravatt, 2006; Tsuboi et al., 2011 ) adult mice were used in this study. NAPE-PLD -/-mice were generated by the deletion of a sequence (from amino acids 99-313) that contains the catalytic domain of the enzyme (Leung et al., 2006; Tsuboi et al., 2011 (Zimmerman, 1983) . Furthermore, we fully followed good laboratory practice and ARRIVE guidelines, and every effort was taken to minimize the number of animals used.
| Rat models of inflammatory and neuropathic pain
Tissue inflammation was induced by injecting 50 ml of 50% complete
Freund's adjuvant (CFA; Thermo Scientific, Billerica, MA) or incomplete
Freund's adjuvant (IFA; Thermo Scientific) subcutaneously into the plantar aspect of the left hind paw of adult rats. The injection was performed under isoflurane-induced anesthesia.
Nerve injury was produced according to previously published protocols (Kim & Chung, 1992) . Briefly, rats were deeply anesthetized with isoflurane, and the fifth lumbar (L5) spinal nerve was exposed and identified after partial laminectomy. A tight 4.0 ligature was then placed around the nerve. The nerve was cut about 5 mm distal from the ligature, and the wound was closed in layers. The sham operation consisted of exposing the L5 spinal nerve without placing the ligature or cutting the nerve.
| Testing pain-related behavior
Inflammation-or nerve injury-induced changes in responses to mechanical stimuli were assessed with an electrical von Frey apparatus (Ugo Basile, Gemonio, Italy). Briefly, rats were placed in a Perspex chamber with a 0.8-cm-diameter mesh flooring and allowed to acclimatize for 15 min. The tip of the probe was pressed against the plantar surface of the paw at a steadily increasing pressure until the animal voluntarily withdrew the paw. The paw-withdrawal threshold was defined as the average weight in grams over three applications. Care was given not to repeat testing on the same paw within 5 min. Responses to mechanical stimuli were assessed every day for 2 days prior to and 3 days after the injection of either CFA or IFA. In animals that were subjected to nerve injury, changes in the sensitivity to mechanical stimulation were assessed every day for 2 days prior to the surgery and then on the second, fourth, and seventh days after the surgery.
Inflammation-or nerve injury-induced changes in responses to noxious heat stimuli were assessed by the Hargreaves test (Hargreaves, Dubner, Brown, Flores, & Joris, 1988) . Briefly, rats were placed in a Perspex box. After a 15-min acclimatization period, an infrared beam (Ugo Basile), which is able to deliver a constantly increasing thermal stimulus, was directed to the plantar surface of the paw. The time until the animal voluntarily withdrew the paw was measured. Again, attention was given not to repeat testing on the same paw within 10 min.
Responses to heat and mechanical stimuli were assessed on the same days.
| Reverse transcription polymerase chain reaction
Rats were killed with isoflurane, and L4 and L5 dorsal root ganglia 
| Western blotting
Rats and mice were killed with isoflurane, and L4 and L5 DRG were collected and homogenized on ice in NP40 cell lysis buffer (Invitrogen) supplemented with a protease inhibitor cocktail (Sigma-Aldrich 
| Immunostaining
Animals were killed by intraperitoneal injection of sodium pentobarbital (60 mg/kg) and perfused through the ascending aorta with 100 ml of 0.9% saline, followed by 300 ml of 4% paraformaldehyde in 0. had extensively tested the specificity and selectivity of the anti-TRPV1, anti-CB1, and anti-FAAH antibodies (Cruz et al., 2008; Lever et al., 2009; Veress et al., 2013) . In addition to the antibodies, fluorescein-labeled Griffonia simplicifolia isolectin B4 (IB4; Sigma-Aldrich) was used to identify the nonpeptidergic subpopulation of nociceptive primary sensory neurons (Silverman & Kruger, 1990) . This was performed by incubating sections in a 1:1,000 dilution of the fluorochrome-conjugated IB4 for 1 hr during the final incubation step for NAPE-PLD staining. Slides were mounted in Vectashield medium (Vector Laboratories, Burlingame, CA).
| Control experiments
For testing the specificity and selectivity of the anti-NAPE-PLD antibody, we first studied proteins identified by the anti-NAPE-PLD antibody in protein samples prepared from the cerebella of WT and NAPE-PLD -/-mice. Furthermore, we studied the immunostaining generated by the anti-NAPE-PLD antibody in sections that had been cut from DRG and cerebellum of WT and NAPE-PLD -/-mice. Finally, we studied the proportion and size distribution of cells expressing NAPE-PLD mRNA as well as the coexpression pattern between NAPE-PLD mRNA and NAPE-PLD protein (vide infra).
| Fluorescent in situ hybridization
Fluorescent in situ hybridization was carried out with a custom Stellaris FISH probe kit, which contains 48 fluorescent dye-conjugated NAPE-PLD mRNA complementary short probes (Biosearch Technologies, Petaluma, CA). All material and stock solutions were treated with diethyl pyrocarbonate (DEPC; Sigma-Aldrich) or RNase ZAP (Sigma-Aldrich) or kept at -808C for 8 hr to prevent RNA degradation. The DEPC treatment included adding 2.5 mM DEPC to all solutions and autoclaving.
DRG sections mounted on coverslips were washed with PBS and then permeabilized with 70% ethanol for 1 hr at room temperature. After having been rinsed in washing buffer that contained 20% formamide and 2 3 concentrated saline sodium citrate (SSC) buffer that contained sodium chloride and trisodium citrate, slides were incubated with the NAPE-PLD probe (2.5 mM) in hybridization buffer (2 3 SSC buffer, 10%
formamide, and 100 mg/ml dextran sulfate) at room temperature for 24 hr. On the next day, after a 1-hr incubation in the washing buffer, slides were immunoreacted with the NAPE-PLD antibody as described above. For control, sections were incubated as described above, but the NAPE-PLD probes were omitted from the hybridization buffer.
Control sections were run in parallel with sections incubated in the presence of the NAPE-PLD probes.
| Image analysis and quantification of immunofluorescent DRG cells
Immunofluorescent images were examined with a Leica (Wetzlar, Germany) DMR Fluorescence, Zeiss (Jena, Germany) Axioscope 40, or
Zeiss LSM 700 confocal laser scanning microscope. With the Leica microscope, images were taken by a Hamamatsu CCD camera connected to a PC running QWIN software (Leica). The PC connected to the Zeiss Axioscope 40 ran AxioVision 4.6, whereas the PC connected to the Zeiss LSM 700 microscope ran ZEN software.
With each microscope, corresponding identical acquisition parameters were used and raw, unprocessed images were used for analysis in Image J. Images selected for figures, however, were subjected to contrast and brightness adjustments when we determined that was required.
Neurons that displayed a visible nucleus were identified, and the cytoplasm and the nuclei of these cells were marked as regions of interest (ROI). The area and mean pixel intensity of the ROIs were then measured. At least 200 cells were sampled in each side of each animal in serial sections at a distance of 610 sections (i.e., 100 lm) apart from one another to ensure that each cell with a given staining was included in the analysis only once.
The threshold staining intensity was established by using three independent methods. First, with visual inspections, we confirmed that sections contained both immunopositive and immunonegative cells.
The presence of the two types of neurons was also confirmed by the non normal distribution of the staining intensities in each section (Shapiro-Wilk test). k-Clustering is able to separate variables into a defined number of clusters that then exhibit the greatest possible distinction.
Therefore, we used k-clustering to define two clusters and the intensity values that separate the two groups of neurons in each section.
In the second method, raw intensity values were transformed by using a logarithmic equation ). These values were ranked and displayed on a scatterplot. The initial and last linear parts of the plots were then fitted with a tangent, and the intensity value at the intersection of the two fitted lines was used as a threshold to separate labeled and nonlabeled cells. This initial separation was then used in a discriminant analysis as prediction. This statistical probe also confirmed that the accuracy of the prediction was between 95%
and 100%.
Finally, one blinded experimenter examined images of randomly chosen sections from naive animals, and the immunopositivity or immunonegativity judged by that experimenter was noted; these notes were then associated with the staining intensity values measured in ImageJ. These combined data were then used to determine the threshold of immunopositivity by the receiver operating curve. The ratio of immunopositive and immunonegative cells determined by the three methods did not differ more than 5%. Data presented throughout the article were obtained with the second method.
In addition to establishing the immunopositive and immunonegative cells, intensity values were also used for studying pathologyinduced changes in staining intensities of NAPE-PLD, TRPV1, CB1
receptor, and FAAH immunopositivity as well as pathology-induced changes in the correlation between staining intensities of NAPE-PLD and TRPV1, CB1 receptor, or FAAH immunopositivity.
| Statistical analysis
For naive animals, data from both the left and the right sides were analyzed and used for further statistical analysis. For treated animals, data obtained from the ipsilateral and the contralateral sides of the same treatment group were averaged, tested for normal distribution (Sha- To determine whether NAPE-PLD protein is also expressed in rat DRG, we performed Western blotting. The anti-NAPE-PLD antibody (Aviva Systems Biology) we used throughout this study recognized, in addition to some unknown proteins, a protein with the predicted size of NAPE-PLD (46 kDa) in samples prepared from rat DRG ( Figure   2a ). In addition, the anti-NAPE-PLD antibody also recognized a protein with the predicted size (46 kDa) in WT mouse brain (together with, apparently, the same unknown proteins; Figure 2a ). However, although the antibody recognized the unknown proteins, it did not recognize the specific 46-kDa protein in samples prepared from the brains of NAPE-PLD -/-mice (Figure 2a ).
To confirm that the NAPE-PLD protein is expressed exclusively by neurons in DRG, we incubated sections cut from rat L4-5 DRG with the anti-NAPE-PLD antibody and visualized the staining via TSA. Analysis of the immunostaining revealed that the antibody produced a homogenous staining in the cytoplasm of DRG neurons (Figure 2b ). In addition to DRG neurons, a fluorescent signal was also seen in some satellite cells (Figure 2b ). However, our control experiments revealed that this staining is produced by the TSA reaction when the postfixation time is less than 24 hr (data not shown).
To obtain evidence that the anti-NAPE-PLD antibody produces a selective and specific immunostaining, we immunoreacted cerebellum and DRG sections of WT and NAPE-PLD To provide additional evidence that the anti-NAPE-PLD antibody produces a specific and selective staining, we also combined the immunostaining with in situ hybridization using fluorescent NAPE-PLD probes (Figure 4) (WT/BR). In addition to recognizing a protein with the predicted size of NAPE-PLD (46 kD) in rat DRG and WT mouse brain tissues, the antibody also recognized some unknown proteins in all samples. However, the antibody failed to recognize the protein with the predicted size of NAPE-PLD in NAPE-PLD -/-mouse brain.
Bottom image shows b-actin (42 kD) expression as loading control.
(b) Microphotograph of a section cut from a rat DRG. The anti-NAPE-PLD antibody produced staining in a subpopulation of primary sensory neurons (arrowheads). In addition, satellite cells visible occasionally around primary sensory neurons also exhibit NAPE-PLD immunopositivity (arrows). However, control experiments revealed that this staining is produced by the TSA reaction when the postfixation time is less than 24 hr. Scale bar 5 30 mm DRG neurons that we analyzed, 3,056 were NAPE-PLD immunoreactive (37.60% 6 0.17%, ipsilateral and contralateral sides of nine animals, n 5 18 repeated measurements; Table 1 ). The cell size distribution of Table 1 ). In contrast, 52.05% 6 2.02% (n 5 6) of the cells bound IB4 3.4 | NAPE-PLD shows a high level of coexpression with TRPV1, the CB1 receptor, and FAAH
To discover whether NAPE-PLD could indeed be involved in the formation of an autocrine endocannabinoid/endovanilloid signaling system in a subpopulation of primary sensory neurons, we next assessed the coexpression of NAPE-PLD and FAAH, the CB1 receptor, or TRPV1. Data from the analysis of these combined immunoreactions are shown in Figure 7 and Table 1 . In summary, we found a very high level of coexpression between NAPE-PLD and all the endocannabinoid/endovanilloid signaling-related molecules ( Figure 7 , Table 1 ).
However, significantly more (p 5 .029, Fisher's exact test) NAPE-PLDimmunopositive neurons expressed the CB1 receptor (72.71% 6
1.47%, n 5 6, 349 of 480 cells in three animals) than TRPV1
(59.89% 6 1.33%, n 5 6,304 of 546 cells in the left and right sides of three animals).
We also assessed the correlation between the intensities of NAPE-PLD and the CB1 receptor, TRPV1, or FAAH immunostaining.
Although NAPE-PLD and CB1 receptor immunostaining exhibited a high correlation (R 5 .76 6 .02, n 5 3; Figure 8a ), essentially no correlation was found between NAPE-PLD and TRPV1 immunostaining (R 5 .14 6 .07, n 5 3; Figure 8b ). Furthermore, a weak correlation (R 5 .34 6 .06, n 5 3; data not shown) was found between the intensities of NAPE-PLD and FAAH immunoreactivity. 
| Spinal nerve ligation results in a pronounced reduction of NAPE-PLD immunoreactivity in injured DRG neurons
Nerve injury has been associated with changes in expression in many proteins, including various components of the endocannabinoid/endovanilloid systems and in anandamide levels in DRG (Agarwal et al., Previous research has demonstrated that primary sensory neurons in the DRG adjacent to the injured DRG also show phenotypic changes (Hammond, Ackerman, Holdsworth, & Elzey, 2004; Hudson et al., 2001 ). Therefore, we also assessed NAPE-PLD, TRPV1, CB1, receptor, and FAAH immunostaining in the ipsilateral L4 DRG. We found no Table 4 ).
| DISCUSSION
The present study shows that about one-third of primary sensory neurons in lumbar DRG express NAPE-PLD. The present data also show that about two-thirds to three-quarters of the NAPE-PLD-expressing neurons could be nociceptive because most of the NAPE-PLD-immunopositive cells are small-diameter neurons that are nociceptive in function (Nagy et al., 2004) and that 35%, 50%, and 60% of the NAPE-PLDexpressing cells also express the nociceptive markers CGRP, IB4-binding site, and TRPV1, respectively, (nota bene, CGRP, IB4-binding site, and TRPV1 exhibit significant coexpression in DRG [Nagy et al., 2004] painful events, and even in the brain areas where the information they convey is transmitted (Bennett, Averill, Clary, Priestley, & McMahon, 1996; Breese, George, Pauers, & Stucky, 2005; Perry & Lawson, 1998; Todd, 2010) . Functionally, IB4-binding neurons are associated primarily with responses to noxious mechanical stimuli and the development of mechanical pain, although they may also contribute significantly to the development of thermal pain following nerve injury (Cavanaugh et al., 2009; Vilceanu, Honore, Hogan, & Stucky, 2010) . Therefore, if NAPE-PLD is involved in nociceptive processing in primary sensory neurons, its activity could contribute to the regulation of mechanosensitivity and the development of mechanical pain.
Among the putative enzymatic pathways that are implicated in converting NAPE into N-acylethanolamine (NAEA), including anandamide (Liu et al., 2006 Okamoto et al., 2004; , the NAPE-PLD-catalyzed pathway is the only one known to be Ca 21 -sensitive (Okamoto et al., 2004; Tsuboi et al., 2011; Ueda et al., 2001; Wang et al., 2006 Wang et al., , 2008 . van der Stelt and colleagues (2005) reported that increasing the intracellular Ca 21 concentration results in anandamide synthesis in cultured primary sensory neurons.
These data indicate that NAPE-PLD is functional in cultured primary sensory neurons.
In addition to anandamide, related molecules, including palmitoyle- et al., 2007) . Furthermore, PEA (and anandamide) also activates GPR55 (Lauckner et al., 2008; Ryberg et al., 2007) . Although PPARa is expressed in both small-and large-diameter cells, GPR55 is expressed primarily in NF200-expressing large-diameter cells (Lauckner et al., 2008; Lo Verme et al., 2005) . Therefore, the expression pattern of NAPE-PLD that we found in the present study suggests that NAPE-PLD, in addition to signaling through the CB1 receptor and TRPV1, could also be involved in signaling through PPARa and GPR55 in subpopulations of primary sensory neurons. NAPE-PLD exhibits a high degree of coexpression with both TRPV1 and the CB1 receptor. We have also demonstrated here that NAPE-PLD shows a high degree of coexpression with FAAH, which is expressed in the majority of TRPV1-expressing primary sensory neurons (Lever et al., 2009) . Considering the coexpression patterns we found in the present study together with those published previously on TRPV1 and the CB1 receptor and on TRPV1 and FAAH coexpression (Agarwal et al., 2007; Ahluwalia et al., 2000; Binzen et al., 2006; Lever et al., 2009; Mitrirattanakul et al., 2006) , it appears that the anatomical basis for an anandamide-, TRPV1-, CB1 receptor-, and FAAH-mediated autocrine signaling system indeed exists in the majority of nociceptive primary sensory neurons. Our recent finding that TRPV1 shows a high degree of coexpression with some of the enzymes implicated in Ca 21 -insensitive anandamide synthesis suggests that anandamide could be synthesized both in Ca
21
-sensitive and in Ca 21 -insensitive manners in at least some of those primary sensory neurons.
Although TRPV1 activation by anandamide results in excitation (Ahluwalia et al., 2003; Potenzieri, Brink, & Simone, 2009; Zygmunt et al., 1999) , CB1 receptor activation by this agent is generally considered as inhibitory in nociceptive primary sensory neurons (Calignano, La Rana, Giuffrida, & Piomelli, 1998; Chen et al., 2016; Clapper et al., 2010; Kelly, Jhaveri, Sagar, Kendall, & Chapman, 2003; Richardson, Kilo, & Hargreaves, 1998) . The CB1 receptor-mediated inhibitory effect in those neurons results, inter alia, in the reduction of TRPV1-mediated responses (Binzen et al., 2006; Mahmud, Santha, Paule, & Nagy, 2009; Santha, Jenes, Somogyi, & Nagy, 2010) . By hydrolyzing anandamide, FAAH could serve as a brake in both the anandamide-induced TRPV1-and CB1 receptor-mediated effects.
We recently showed that, although anandamide produced in a Ca 21 -insensitive fashion in cultured primary sensory neurons induces TRPV1-mediated excitation, it does not produce a CB1 receptormediated inhibitory effect when the inhibitory effect is assessed by measuring TRPV1-mediated responses . The finding that Ca
-sensitive anandamide production in primary sensory neurons results in TRPV1-mediated excitatory effects suggests that NAPE-PLD activity could also be associated with TRPV1
activation. However, although we found a strong correlation between NAPE-PLD-and CB1 receptor-immunostaining intensities, the correlation between NAPE-PLD-and TRPV1-immunostaining intensities is very low. These data suggest that, at least in intact DRG, NAPE-PLD activity may be linked to the CB1 receptor rather than to TRPV1 acti- -insensitive manner has differing primary targets in primary sensory neurons, the anandamide-, CB1 receptor-, TRPV1-, and FAAHformed putative autocrine signaling system could exert a very delicate control over the activity of a major proportion of nociceptive cells and, hence, over the development of pain. Consequently, any change in the expression or activity of any members of that system could disturb balanced signaling that may contribute to the development of pain.
Our data indicate that various types of painful disturbances of the homeostasis of peripheral tissues are able to produce such perturbation. Whereas CFA is used to induce a painful inflammatory reaction, IFA is used as its control, although IFA injection itself induces some inflammatory reaction and even hypersensitivity (Billiau & Matthys, 2001 (Amaya et al., 2006) . Furthermore, the lack of increase in the number of TRPV1-expressing cells is also surprising because it differs from data that had been reported earlier (Amaya et al., 2004 (Amaya et al., , 2006 Ji et al., 2002; Luo et al., 2004; Yu et al., 2008 ; but see Bar et al., 2004; Zhou et al., 2003) . These differences could be due to the use of different analyzing techniques in the different studies. Nevertheless, the combined effects of the changes that we observed suggest that a balanced signaling between anandamide of NAPE-PLD origin and TRPV1 and the CB1 receptor is tipped toward a signaling with increased excitatory and reduced inhibitory components. However, the contribution of this unbalanced signaling could be negligible because, although the CFA injection-induced hypersensitivity is significantly greater than that produced by IFA injection, the changes in the expression pattern of the molecules are not. showing that NAPE-PLD mRNA expression is reduced in the injuryaffected DRG in another neuropathic pain model, the so-called spared nerve injury model (Bishay et al., 2010) . Nerve injury-induced downregulation of NAPE-PLD expression is associated with a reduction in NAEA content, including that of anandamide, of the affected DRG (Bishay et al., 2010 (Bishay et al., , 2013 Mitrirattanakul et al., 2006) . The nerve injury-induced upregulation of FAAH expression is also consistent with results from previous studies (Bishay et al., 2010) , although, in our earlier study (Lever et al., 2009) , the increase in the proportion of FAAHexpressing neurons did not reach the level of significance. This discrepancy between our present and previous data could be due to the transient nature of upregulation of FAAH expression, which reaches its peak on the seventh day after the injury (Bishay et al., 2010) . Although we assessed nerve injury-induced changes 7 days after the surgery in both studies, because of possible slight differences in surgery techniques used by different persons, the time course of changes could be different. Nevertheless, the changes we found in CB1 receptor expression are generally consistent with previous reports (Costigan et al., 2002; Mitrirattanakul et al., 2006; Zhang et al., 2007) . Finally, in addition to changes in the proportions of NAPE-PLD-, CB1 receptor-, and FAAH-expressing neurons, the proportion of TRPV1-expressing DRG neurons is also dramatically reduced by SNL. This change is similar to that reported earlier by others who used the same neuropathic model (Hudson et al., 2001; Lever et al., 2009 ). This reduced TRPV1 expression is consistent with the limited role of this ion channel in the development of pain following peripheral nerve injury (Caterina et al., 2000) .
In summary, this study shows that a major proportion of primary sensory neurons express NAPE-PLD. We also show that NAPE-PLD exhibits a high degree of coexpression with TRPV1, the CB1 receptor, and FAAH, indicating that NAPE-PLD indeed could be involved in an autocrine regulatory mechanism in a major proportion of nociceptive primary sensory neurons. Finally, we show that, although peripheral inflammation and injury to peripheral nerves induce differing changes in the expression pattern of NAPE-PLD, the CB1 receptor, TRPV1, and FAAH, both sets of changes are highly likely to produce unbalanced signaling in that autocrine regulatory system and that unbalanced signaling is characterized primarily by reduced anandamide-induced and CB1 receptor-mediated activity and, hence, reduced inhibition on the activity and excitability of primary sensory neurons. Similar unbalanced endocannabinoid/endovanilloid signaling because of reduction in CB1
receptor-mediated inhibitory effects in primary sensory neurons as well as in the spinal cord has been shown to contribute to the development of pain in various animal models of persistent pain (Bishay et al., 2010; Guasti et al., 2009; Jhaveri, Richardson, Kendall, Barrett, & Chapman, 2006; Khasabova et al., 2008 Khasabova et al., , 2012 Khasabova et al., , 2013 Starowicz et al., , 2013 .
The findings we present here provide the first insight into an autocrine signaling system that is highly likely to play an important role in regulating the excitability of a major group of nociceptive primary sensory neurons. This insight is important because it suggests that pharmacological manipulation of this system might provide a significant reduction in spinal nociceptive input and, hence, reduction in pain associated with peripheral pathologies. However, full utilization of the putative analgesic potential of this system requires further elucidation of the signaling mechanism. For example, we recently showed that spatial proximity and protein-protein interactions between TRPV1 and the CB1 receptor may determine how the CB1 receptor affects TRPV1 activity (Chen et al., 2016) . Similarly, the spatial relationship between FAAH and TRPV1 and/or the CB1 receptor, which is currently unknown, is of high importance because it determines whether FAAH activity directs anandamide away from the CB1 receptor or TRPV1.
Furthermore, although our data suggest that anandamide synthesized by NAPE-PLD may preferentially activate the CB1 receptor, this assumption requires further support.
It is also important to note that, to avoid inducing undesirable effects, manipulation of the endocannabinoid/endovanilloid autocrine signaling system even outside the blood-brain barrier should occur in a cell-specific manner (i.e., in nociceptive primary sensory neurons) because several components of the endocannabinoid/endovanilloid system exhibit widespread expression patterns. Therefore, although the CB1 receptor and TRPV1 outside the central nervous system are expressed almost exclusively by nociceptive primary sensory neurons (Agarwal et al., 2007; Ahluwalia et al., 2000; Binzen et al., 2006; Caterina et al., 1997; Mitrirattanakul et al., 2006; Sousa-Valente, Andreou, et al., 2014; Tominaga et al., 1998; Veress et al., 2013) , both NAPE-PLD and FAAH are expressed by various cells and are involved in various physiological functions (Alhouayek & Muccioli, 2012; Geurts et al., 2015; Guo et al., 2005; Paria, Zhao, Wang, Das, & Dey, 1999; Rossi et al., 2009 ). Nevertheless, our data indicate that NAPE-PLD could be another important molecule of the endocannabinoid/endovanilloid system that controls nociceptive processing in primary sensory neurons. Therefore, we propose that NAPE-PLD in nociceptive primary sensory neurons could be a valuable novel target for the development of new analgesics.
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